Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Mar 15, 2026; 18(3): 115835
Published online Mar 15, 2026. doi: 10.4251/wjgo.v18.i3.115835
Published online Mar 15, 2026. doi: 10.4251/wjgo.v18.i3.115835
Table 1 Clinical relevance of gastric cancer stem cells key markers and their significance
| Gene/marker | Clinical significance |
| CD44 | Common GCSC marker; associated with self-renewal, metastasis, and poor prognosis |
| CD133 | Identifies chemoresistant GCSCs; linked with tumor initiation and relapse |
| ALDH1A1 | Enzyme marker of stemness; correlates with advanced disease and survival |
| EpCAM | Cell adhesion molecule; supports tumor-initiating capacity |
| SOX2, NANOG, OCT4 | Pluripotency transcription factors; sustain stem-like properties and correlate with aggressive phenotypes |
| LGR5 | Stem cell receptor; marks progenitor-like GCSCs with poor clinical outcomes |
- Citation: Prisacariu IA, Koumarelas KE, Papadopoulos P, Schizas D, Christodoulidis G. From bench to bedside: Stem cell applications in gastric cancer therapy and their emerging clinical relevance. World J Gastrointest Oncol 2026; 18(3): 115835
- URL: https://www.wjgnet.com/1948-5204/full/v18/i3/115835.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i3.115835